Retatrutide Weight Loss Research Peptide

10mg*10vials

¥88.00

¥88.00 ¥288.00

Retatrutide Weight Loss Research Peptide

¥88.00

¥88.00 ¥288.00

Dosage Volume 10mg*10vials 20mg*10vials 30mg*10vials 40mg*10vials

Groundbreaking Dual-Receptor Synergistic Mechanism

The core advantage of dual-receptor agonists lies in their complementary dual-pathway regulation, solving multiple metabolic root causes at once, rather than relieving superficial symptoms. Each receptor plays an irreplaceable role in reshaping body composition and metabolic health, working together to form an efficient fat-burning and metabolic repair loop.

1. GLP-1 Receptor Activation: Control Appetite & Stabilize Glycemia

GLP-1 pathway targeting acts on the central nervous system and gastrointestinal tract to significantly enhance satiety, curb emotional eating and sugar cravings, and delay gastric emptying. It effectively reduces daily calorie intake without triggering extreme hunger or fatigue. Meanwhile, it promotes glucose-dependent insulin secretion, suppresses excessive glucagon release, and stably regulates blood sugar levels, improving overall glycemic control and eliminating blood sugar spikes and crashes that trigger fat accumulation.

2. GIP/GCG Receptor Activation: Boost Fat Burning & Rewire Metabolism

Complementing GLP-1’s appetite control effect, the second receptor activation brings unique fat-loss and metabolic benefits that single GLP-1 drugs cannot achieve. It directly stimulates adipose tissue lipolysis, increases whole-body energy expenditure and fat oxidation, and specifically targets and breaks down stubborn visceral abdominal fat. Clinical data confirms it can reduce visceral fat by up to 40.1%, fundamentally improving fat distribution.

Additionally, this pathway significantly enhances insulin sensitivity, repairs impaired lipid metabolism, reduces liver fat deposition, and optimizes abnormal blood lipid indicators. It reverses the core metabolic problems of obesity, insulin resistance, and dyslipidemia, completely breaking the vicious cycle of “slow metabolism → fat gain → worse metabolism”.

Clinical-Proven Powerful Weight Loss & Metabolic Benefits

Global phase III clinical trials have verified the extraordinary efficacy of dual-receptor agonists, delivering transformative results beyond traditional weight loss solutions:

Superior Dose-Dependent Weight Loss: Achieve an average of 12.8%–14.7% total body weight reduction in long-term treatment, with some users losing over 30% of their body mass. The fat-to-lean mass loss ratio reaches 3:1, focusing on fat loss while preserving precious lean muscle to avoid body sagging and metabolic decline.
Eliminate Stubborn Visceral Fat: Preferentially burn harmful visceral fat surrounding vital organs, the main culprit of metabolic syndrome, solving the long-term problem of unremovable belly fat.
Full Metabolic Reset: Effectively improve insulin resistance, normalize blood glucose, triglycerides and lipid levels, reduce chronic adipose inflammation, and repair hepatic metabolic function, achieving comprehensive metabolic rejuvenation.
Strong Anti-Rebound Ability: Different from temporary water weight loss, it reshapes the body’s basal metabolic level and fat regulation mechanism, greatly reducing the risk of weight rebound after treatment.

Core Advantages Over Traditional Weight Loss & Single-Target Drugs

1+1>2 Synergistic Effect: Dual-pathway coordination achieves far better weight loss and metabolic regulation than single GLP-1 agonists, breaking treatment plateaus easily.
Muscle-Sparing Body Recomposition: Prioritize fat decomposition, protect lean muscle mass, maintain tight body contours and healthy basal metabolism.
Root-Cause Treatment: Not only reduce weight, but also repair underlying metabolic disorders, realizing long-term health improvement rather than temporary results.
High Safety & Tolerability: Glucose-dependent regulation avoids hypoglycemia risks, with mild and controllable side effects, suitable for long-term standardized use.
Once-Weekly Convenient Dosing: Long-acting formulation reduces frequent medication troubles, greatly improving long-term treatment adherence.

Ideal Candidate Groups

Dual-receptor agonist metabolic and weight loss therapy is perfectly tailored for modern adults with stubborn metabolic and weight problems:

Individuals with stubborn obesity and belly fat that cannot be improved by diet and exercise
Users who hit weight loss plateaus with single GLP-1 treatments
People with metabolic syndrome, insulin resistance, and unbalanced blood sugar and lipids
Those prone to weight rebound and slow metabolic recovery
Health pursuers seeking efficient fat loss and long-term metabolic health maintenance

，High-quality and low-cost peptides, directly from the source factory, with a complete range of products. We are experienced and professional peptide exporters, offering safe and fast delivery, as well as stable and reliable after-sales guarantee. Welcome to consult and purchase.